Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.59 - $6.97 $58,653 - $113,875
-16,338 Closed
0 $0
Q2 2024

Aug 14, 2024

SELL
$3.38 - $7.86 $1,892 - $4,401
-560 Reduced 3.31%
16,338 $61,000
Q1 2024

May 13, 2024

BUY
$4.26 - $8.46 $71,985 - $142,957
16,898 New
16,898 $119,000
Q3 2022

Nov 07, 2022

BUY
$7.17 - $12.16 $130,494 - $221,312
18,200 New
18,200 $149,000

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $329M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.